Sunita KC Basnet

Dr Sunita KC Basnet is a postdoctoral researcher in the Molecular & Proximity Discovery (MPD) Laboratory, led by Dr Michael Roy, within the Resistance Prevention Program at the South Australian immunoGENomics Cancer Institute (SAiGENCI). She holds a PhD in Pharmacy from the University of South Australia, where her research focused on the identification and preclinical development of novel kinase inhibitors for cancer treatment. Dr Basnet brings extensive expertise in cancer biology, pharmacology, and drug discovery, with a particular emphasis on cyclin-dependent kinase inhibitors and the use of both in vitro and in vivo cancer models. Following her PhD, she continued working with Professor Shudong Wang in the Drug Discovery and Development group at UniSA, contributing to the development of several targeted anti-cancer agents. Her current research explores the discovery of small molecule Targeted Protein Degraders and Molecular Glues aimed at overcoming drug resistance and addressing previously 'undruggable' targets in cancer signalling pathways. Drug discovery, Cancer Cell Biology

[2026] van der Noord, V. E., McLaughlin, R. P., Karuntu, J. S., He, J., Timmermans, A. M., Basnet, S. K. C., . . . van de Water, B. (2026). Disrupting CDK9 activity suppresses triple-negative breast cancer and is enhanced by EGFR Inhibition. Cellular Oncology Dordrecht Netherlands, 49(1), 20. [2026] Safaroghli-Azar, A., Croft, T., Mekonnen, L. B., Lenjisa, J., Dickel, M., Shrestha, R. K., . . . Wang, S. (2026). CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer. Journal of Experimental and Clinical Cancer Research, 45(1), 188-1-188-23. [2026] Midorikawa, R., Wakazono, Y., Basnet, S. K. C., Kandel, M. B., Uchida, T., Morise, J., . . . Takamiya, K. (2026). A single extracellular glycan links AMPA receptor gating to synaptic plasticity and memo